February 7, 2018 / 8:40 PM / 5 months ago

BRIEF-Aviragen And Vaxart Amend Terms Of Merger Agreement To Increase The Value For Aviragen Stockholders

Feb 7 (Reuters) - Aviragen Therapeutics Inc:

* AVIRAGEN AND VAXART AMEND TERMS OF MERGER AGREEMENT TO INCREASE THE VALUE FOR AVIRAGEN STOCKHOLDERS

* AVIRAGEN THERAPEUTICS INC - AVIRAGEN STOCKHOLDERS WOULD NOW OWN 49% OF COMBINED COMPANY, UP FROM 40% UNDER PREVIOUS AGREEMENT

* AVIRAGEN THERAPEUTICS INC - AMENDED AGREEMENT HAS BEEN UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES

* AVIRAGEN THERAPEUTICS INC - AVIRAGEN BOARD RECOMMENDS AVIRAGEN STOCKHOLDERS VOTE FOR MERGER AT SPECIAL MEETING OF STOCKHOLDERS ON FEBRUARY 9, 2018

* AVIRAGEN THERAPEUTICS INC - ‍INTENDS TO RECONVENE SPECIAL MEETING OF STOCKHOLDERS TO VOTE ON PROPOSED MERGER ON FEB 9, 2018 AT 12:00 PM EST​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below